Clinical Trial Update: Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment [Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 2 trial evaluating AMB-05X in patients with ctDNA-positive colorectal cancer after curative-intent treatment. Recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AMB-05X

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING